Latest Breaking News On - Phase 1 skybridge trial nct05652686 - Page 1 : comparemela.com

FDA Grants Fast Track Designation to PT217 for Extensive Stage Small Cell Lung Cancer

The FDA has granted fast track designation to PT217 for patients with extensive stage small cell lung cancer with disease progression.